This exploratory pilot study also reported a decrease in baseline/interictal saliva CGRP levels for participants receiving BoNT, although this difference was only observed after the third month and narrowly missed statistical significance when compared to placebo-control group.
← all excerpts
Botulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions: a systematic review of clinical research.
1
—
—